Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Merck KGaA

Start price
Target price
Perf. (%)
€124.80
23.09.20
-
04.11.21
4.17%
25.11.20

ROE higher than 10% per year
Low dividend yield expected
Phunware Inc.

Start price
Target price
Perf. (%)
€0.70
23.09.20
-
22.10.20
-11.43%
22.10.20

Risky Investment
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€1.41
23.09.20
-
04.11.21
1369.50%
15.07.21

Risky Investment
Kandi Technologies Corp.

Start price
Target price
Perf. (%)
€4.83
23.09.20
€3.70
09.10.20
30.15%
09.10.20

EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
Washington Prime Group Inc.

Start price
Target price
Perf. (%)
€4.58
23.09.20
€3.60
04.11.21
3.91%
04.11.20

Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
NIO Inc. ADR

Start price
Target price
Perf. (%)
€15.55
23.09.20
€12.00
13.10.20
17.36%
13.10.20

Probably not worthwhile Investment
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€8.90
23.09.20
-
26.10.20
-25.84%
26.10.20

Could be very worthwhile Investment >20% year
Nikola Corp.

Start price
Target price
Perf. (%)
€23.10
23.09.20
-
24.09.20
-39.39%
24.09.20

Risky Investment
overvalued
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.45
23.09.20
-
04.11.21
-47.51%
15.07.21

Probably not worthwhile Investment
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€71.00
23.09.20
-
26.10.20
-7.82%
26.10.20

Could be very worthwhile Investment >20% year
Inovio Pharma

Start price
Target price
Perf. (%)
€13.60
23.09.20
-
26.10.20
-31.99%
26.10.20

Risky Investment
buy
Orange S.A.

Start price
Target price
Perf. (%)
€9.30
23.09.20
€15.00
04.11.21
5.51%
11.02.21

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Small cyclical dependencies
buy
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€9.21
23.09.20
€14.00
04.11.21
692.62%
05.11.21

Fair valuation
Some uniques
Future proof or reliable business model
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€2.26
23.09.20
-
04.11.21
1984.35%
05.11.21

Could be worthwhile Investment >10% per year
Oz Minerals Ltd

Start price
Target price
Perf. (%)
€8.55
23.09.20
-
04.11.21
77.16%
05.11.21

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.43
23.09.20
€36.00
04.11.21
58.26%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
Tesla Inc

Start price
Target price
Perf. (%)
€115.42
23.09.20
-
04.11.21
22.37%
23.11.20

Very capable Management
Workhorse Group Inc

Start price
Target price
Perf. (%)
€22.01
23.09.20
-
04.11.21
-36.44%
01.03.21

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
B2gold Corp.

Start price
Target price
Perf. (%)
€5.52
23.09.20
-
04.11.21
-6.45%
12.11.20

Could be very worthwhile Investment >20% year
Below average Marketposition
Very high cyclical dependencies
Unknown brand
buy
Accell Group NV

Start price
Target price
Perf. (%)
€24.15
22.09.20
€50.00
04.11.21
55.90%
05.11.21

Could be worthwhile Investment >10% per year
buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€440.00
22.09.20
-
04.11.21
47.73%
05.11.21

AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
22.09.20
€78.00
04.11.21
-0.76%
07.06.21

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
22.09.20
-
04.11.21
-49.70%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Gogold Resources Inc.

Start price
Target price
Perf. (%)
€0.95
22.09.20
-
04.11.21
151.84%
05.11.21

Could be very worthwhile Investment >20% year
Chalice Gold Mines Ltd

Start price
Target price
Perf. (%)
€1.41
22.09.20
-
04.11.21
210.89%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected